Is the Metabolism of Alfentanil Subject to Debrisoquine Polymorphism? A Study Using Human Liver Microsomes
¶ McDonnell TE, Bartkowski RR, Kahn C: Evidence for polymorphic oxidation of alfentanil in man (abstract). ANESTHESIOLOGY 61:A284, 1984.
** Kahn C, Rubenfield H, Bartkowski R, McDonnell TE: Competitive inhibition of debrisoquine and phenacetin oxidation by alfentanil in human liver (abstract). North American Symposium on Risk Assessment and the Biological Fate of Xenobiotics, Florida, International Society for the Study of Xenobiotics, 1985, p 31.
Karel L. M. Lavrijsen, Jos M. G. Van Houdt, Dirk M. J. Van Dyck, Jan J. J. M. Hendrickx, Robert J. H. Woestenborghs, William Lauwers, Willem E. G. Meuldermans, Joseph J. P. Heykants; Is the Metabolism of Alfentanil Subject to Debrisoquine Polymorphism? A Study Using Human Liver Microsomes. Anesthesiology 1988; 69:535–540 doi: https://doi.org/10.1097/00000542-198810000-00013
Download citation file: